Who owns BOLT BIOTHERAPEUTICS INC?
- Ticker: BOLT
- CUSIP Number: 097702104
Tip: Access positions for across all investors
Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bolt Biotherapeutics stock
Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Tang Capital Management | 3.8M | $2.5M | 0% | Sep 2024 |
|
| Sofinnova Ventures | 2.8M | $1.8M | 0% | Sep 2024 |
|
| Pivotal bioVenture Partners Investment Advisor | 1.9M | $1.2M | 0% | Sep 2024 |
|
| Nan Fung Group Holdings | 1.2M | $756k | 0% | Sep 2024 |
|
| Vanguard Group | 1.1M | $801k | 3% | Jun 2024 |
|
| Samsara BioCapital | 1.0M | $680k | 0% | Sep 2024 |
|
| Board of Trustees of The Leland Stanford Junior University | 720k | $466k | 0% | Sep 2024 |
|
| Newtyn Management | 469k | $304k | -66% | Sep 2024 |
|
| Geode Capital Management | 352k | $228k | -5% | Sep 2024 |
|
| Renaissance Technologies | 294k | $191k | 6% | Sep 2024 |
|
| BlackRock | 270k | $175k | 100% | Sep 2024 |
|
| BlackRock | 267k | $200k | 5% | Jun 2024 |
|
| Susquehanna International | 148k | $96k | 560% | Sep 2024 |
|
| Bridgeway Capital Management | 85k | $64k | -23% | Jun 2024 |
|
| Two Sigma Securities | 54k | $40k | 126% | Jun 2024 |
|
| State Street Corporation | 47k | $36k | 0% | Jun 2024 |
|
| Northern Trust | 41k | $27k | 0% | Sep 2024 |
|
| Mariner Wealth Advisors | 41k | $26k | 100% | Sep 2024 |
|
| Morgan Stanley | 34k | $34k | 36% | Jun 2024 |
|
| Jane Street | 28k | $18k | -32% | Sep 2024 |
|
| Assenagon Asset Management | 21k | $14k | -40% | Sep 2024 |
|
| Advisor Group Holdings | 17k | $11k | 16% | Sep 2024 |
|
| Bank of America Corporation | 6.0k | $3.9k | 855% | Sep 2024 |
|
| Steward Partners Investment Advisory | 1.0k | $750.000000 | 100% | Jun 2024 |
|
| Jpmorgan Chase & Co | 914.00 | $591.906400 | 9% | Sep 2024 |
|
| Tower Research Capital | 184.00 | $138.000000 | -97% | Jun 2024 |
|
| Barclays | 139.00 | $0 | 0% | Sep 2024 |
|
| Salem Investment Counselors | 40.00 | $26.000000 | 0% | Sep 2024 |
|
| Qube Research & Technologies | 2.00 | $2.000000 | 0% | Jun 2024 |
|
Who sold out of Bolt Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2024 | 2.4M | $1.8M |
| Acuitas Investments | Jun 2024 | 631k | $473k |
| Marquette Asset Management | Jun 2024 | 114k | $85k |
| Squarepoint Ops | Mar 2024 | 78k | $109k |
| Royal Bank of Canada | Jun 2024 | 358.00 | $0 |